Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aderamastat by Foresee Pharmaceuticals for Asthma: Likelihood of Approval
Aderamastat is under clinical development by Foresee Pharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase II...
Aderamastat by Foresee Pharmaceuticals for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
Aderamastat is under clinical development by Foresee Pharmaceuticals and currently in Phase II for Chronic Obstructive Pulmonary Disease (COPD). According...
Aderamastat by Foresee Pharmaceuticals for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Likelihood of Approval
Aderamastat is under clinical development by Foresee Pharmaceuticals and currently in Phase I for Interstitial Lung Diseases (Diffuse Parenchymal Lung...
Aderamastat by Foresee Pharmaceuticals for Sarcoidosis: Likelihood of Approval
Aderamastat is under clinical development by Foresee Pharmaceuticals and currently in Phase I for Sarcoidosis. According to GlobalData, Phase I...